<DOC>
	<DOC>NCT00726648</DOC>
	<brief_summary>Comparison of the effects of different CDP323 doses given over a period of four weeks on blood biomarkers in subjects with relapsing forms of multiple sclerosis.</brief_summary>
	<brief_title>CDP323 Biomarker Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Female and male subjects aged 1865 years Relapsing form of MS with at least one clinical relapse in the 24 months before screening; Screening EDSS score of 06.5; Must be fully immunocompetent Female subjects of childbearing potential must agree to practice contraception methods Any conditions that could interfere with the contrastenhanced MRI; Any clinically significant disease state or findings other than MS; Any clinically significant deviation from the predefined ranges for laboratory tests; Concomitant treatment with MS disease modifying drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>CDP323</keyword>
	<keyword>Relapsing multiple sclerosis</keyword>
	<keyword>Blood biomarkers</keyword>
</DOC>